scispace - formally typeset
K

Karin Johansson

Researcher at Lund University

Publications -  77
Citations -  2861

Karin Johansson is an academic researcher from Lund University. The author has contributed to research in topics: Breast cancer & Lymphedema. The author has an hindex of 22, co-authored 67 publications receiving 2467 citations. Previous affiliations of Karin Johansson include American Physical Therapy Association.

Papers
More filters
Journal ArticleDOI

Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial

TL;DR: Early treatment with compression garment can prevent progression in mild BCRAL, and subjective symptoms did not differ between the groups, except at 1 month, where the CG experienced more reduced tension.
Journal ArticleDOI

The Body Image and Relationship Scale: A Swedish translation, cultural adaptation, and reliability and validity testing

TL;DR: The BIRS-S demonstrates satisfactory test–retest reliability and validity according to the primary hypothesis of a moderate correlation to SF-36, an adapted version of the original instrument including specific areas of importance for Swedish breast cancer survivors.
Journal ArticleDOI

The Effect of Exercise for the Prevention and Treatment of Cancer-Related Lymphedema: A Systematic Review with Meta-analysis

TL;DR: Findings support the application of exercise guidelines for the wider cancer population to those with or at risk of CRL and include promotion of aerobic and resistance exercise, and not just resistance exercise alone, as well as unsupervised exercise guided by symptom response.
Journal ArticleDOI

Prevention of arm lymphedema through the use of compression sleeves following breast cancer: results from a targeted literature review

TL;DR: Findings suggest that use of compression garment was associated with reduced incidence, attenuation of lymphedema or prevention of progression to more severe lyMPhedema, however, the absence of a randomized, controlled trial in the tertiary setting means causal inferences relationship cannot be made.
Journal ArticleDOI

Analysis of Oct2‐Isoform Expression in Lipopolysaccharide‐Stimulated B Lymphocytes

TL;DR: More frequent use of the classical Oct2a and Oct2b isoforms was observed in the lipopolysaccharide‐stimulated B cells, while a preference for the Oct2ab andOct2ba isoformswas observed in lipopoly Saccharide plus phorbol‐di‐butyrate‐lreated cells.